洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 The Development of a New Imaging Modality for Micro-TESE based on the Preliminary First Clinical Trial

【ChiCTR2600123728】The Development of a New Imaging Modality for Micro-TESE based on the Preliminary First Clinical Trial

查看原文
立即下载
基本信息
登记号

ChiCTR2600123728

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-04-29

临床申请受理号

/

靶点

/

适应症

Male Infertility

试验通俗题目

The Development of a New Imaging Modality for Micro-TESE based on the Preliminary First Clinical Trial

试验专业题目

The Need to Develop Micro-TESE in Male Infertility in Light of Current Literature: Investigation of the Clinical Effectiveness of a New Imaging Method

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

34899

联系人通讯地址

/

临床试验信息
试验目的

The primary objective was to evaluate the diagnostic performance of a novel telecentric lens–based imaging system for identifying seminiferous tubules associated with sperm retrieval during micro-TESE in patients with NOA.

试验分类
请登录查看
试验类型

诊断试验诊断准确性

试验分期

诊断试验新技术

随机化

None

盲法

/

试验项目经费来源

This work was funded by a grant from the TUBITAK (The Scientific and Technological Research Council of Turkiye) (Protocol No.121S182). This fund was utilsed yo obtaind instruments (lens, camere etc.).

试验范围

/

目标入组人数

/

实际入组人数

/

第一例入组时间

2020-01-05

试验终止时间

2023-03-14

是否属于一致性

/

入选标准

1. Male patients aged 18–40 years. 2. Diagnosis of non-obstructive azoospermia confirmed by at least two semen analyses. 3. Scheduled to undergo micro-TESE for infertility treatment. 4. Female partner eligible for intracytoplasmic sperm injection (ICSI). 5. Ability to understand the study procedures and willingness to provide written informed consent. 1. Male patients aged 18–40 years.2. Diagnosis of non-obstructive azoospermia confirmed by at least two semen analyses.3. Scheduled to undergo micro-TESE for infertility treatment.4. Female partner eligible for intracytoplasmic sperm injection (ICSI).5. Ability to understand the study procedures and willingness to provide written informed consent.；

排除标准

1. Obstructive azoospermia. 2. Known chromosomal abnormalities incompatible with sperm retrieval. 3. Prior testicular surgery significantly altering anatomy. 4. Inability or refusal to provide consent.；

研究者信息
研究负责人姓名
请登录查看
试验机构

Department of Urology School of Medicine, Marmara University

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

34899

联系人通讯地址

/

更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Department of Urology School of Medicine, Marmara University的其他临床试验

更多

Department of Urology School of Medicine, Marmara University的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品